期刊文献+

益气清肝方联合拉米夫定治疗乙型肝炎肝硬化疗效观察 被引量:4

Effect of Yiqi Qinggan Decoction Combined with Lamivadine for Chronic Hepatitis B Patients with Liver Cirrhosis
原文传递
导出
摘要 目的:观察益气清肝方联合拉米夫定治疗乙型肝炎肝硬化的疗效。方法:将58例患者随机分为2组,治疗组30例以益气清肝方联合拉米夫定治疗,对照组28例单用拉米夫定治疗,疗程52周。观察2组肝功能[谷丙转氨酶(ALT)、血清总胆红素(TBi)l、血清白蛋白(Alb)]、HBV DNA、Child-Pugh积分及乙肝两对半的变化。结果:治疗组患者HBV DNA阴转率高于对照组,2组比较,差异有显著性意义(P<0.05);2组HBeAg/HBeAb血清转换率、HBV DNA-YMDD变异率比较,差异无显著性意义(P>0.05)。2组患者治疗后ALT、TBil、Alb均较治疗前改善,差异均有显著性意义(P<0.05);治疗后治疗组ALT、TBil与对照组比较,差异均有显著性意义(P<0.05)。2组患者治疗后Child-Pugh积分均较治疗前改善,差异均有显著性意义(P<0.05)。结论:益气清肝方联合拉米夫定治疗乙型肝炎肝硬化疗效确切。 Objective= To observe the clinical effect of Yiqi Qinggan Decoction combined with lamivadine for chroni~ hepatitis B patients with liver cirrhosis. Methods. Fifty-eight patients were randomly divided into two groups. The treatment group with thirty cases was treated with Yiqi Qinggan Decoction combined with lamivadine, and the control group with twenty-eight cases was given lamivadine. The treatment lasted fifty-two weeks. The changes of liver function parameters including alanine aminotransferase(ALT), total bilirubin(TBil) and albumin(AIb), as well as hepatitis B virus(HBV)DNA quantitation, Child-Pugh scores and HBV markers were detected. Results= The negative conversion rate of HBV DNA in the treatment group was higher than that in the control group, the difference being significant(P 〈 0.05).The differences of HBeAg/HBeAb seroconversion rate and HBV DNA-YMDD mutation rate were not significant between the two groups(P 〉 0.05). After treatment, liver function (ALT, TBil and AIb)was improved significantly in both groups(P 〈 0.05 compared with that before treatment). The improvement of ALT and TBil of the treatment group was more significant than that of the control group. After treatment, Child-Pugh scores in both groups were improved significantly(P 〈 0.05 compared with those before treatment). Conclusion: Yiqi Qinggan Decoction combined with lamivadine has certain effect for hepatitis B patients with liver cirrhosis.
出处 《新中医》 CAS 2012年第3期30-32,共3页 New Chinese Medicine
基金 江苏省中医药局项目(编号:LZ09029) 国家中医药管理局中医药重点学科(中医肝胆病学)建设项目
关键词 肝硬化 乙型肝炎 中西医结合疗法 益气清肝方 拉米夫定 Liver Cirrhosis Hepatitis B Integrated Chinese and Western Medicine Therapy Yiqi Qinggan Decoction,,Lamivadine
  • 相关文献

参考文献6

二级参考文献52

共引文献16

同被引文献27

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部